Autoimmune profile of rat blood in experimental ulcerative colitis

Cover Page

Cite item

Abstract

Worldwide incidence of digestive system disorders doubles each decade, thus representing a significant medical and social problem. Despite lacking knowledge in pathogenesis of inflammatory bowel diseases, it is clear that serum cytokine imbalance, and lesions in the walls of gastrointestinal tract are observed in experimental colitis. Pathogenesis of UC remains controversial due to a large set of etiological factors that initiate activation of cellular and humoral mechanisms of the immune response upon development of inflammatory changes in the large intestine. At the same time, cytokine secretion and expression have not been studied in details. The aim of the work was to study the cytokine profile of blood in rats using the experimental oxazolone model of ulcerative colitis. The work was performed in 40 white Wistar rats; ulcerative colitis was induced by rectal administration of a 3% alcohol solution of oxazolone. For anesthesia, Zoletil-100 (INN: tiletamine hydrochloride, VirbacSanteAnimale; France) was used at a dose of 20 mg/kg. The studies were carried out on the 2nd, 4th and 6th days. Serum concentration of IL-6, IL-8, IL-17 and IL-23 was determined by means of automatic ELISA analyzer “Personal LAB” using a specific test system for rats. For immunohistochemistry of Treg cells, we used anti-FoxP3 antibody (Arigo Biolaboratories, Тайвань) followed by immunhistostaining in VENTANA BenchMark XT (USA). Statistical evaluation was performed by non-parametric Mann-Whitney and Wald-Wolfowitz criteria. The difference was considered significant at р ≤ 0.05. In rats with experimental colitis, an increase of proinflammatory IL-17 which acts by attraction of neutrophils and other cells of innate immunity, supporting chronic inflammation and autoimmune reactions. We have found an increase of serum IL-23 concentration in rats with experimental ulcerative colitis on days 2, 4 and 6 of the experiment. This cytokine induces and maintains the inflammatory process in the wall of the large intestine. Significant decrease of FoxP3+Т-lymphocytes was revealed in colonic tissues, thus suggesting appropriate local autoimmune disorders.

About the authors

E. V. Davydova

South Ural State Medical University

Author for correspondence.
Email: davidova-ev.med@yandex.ru

Evgeniya V. Davydova - PhD, MD (Medicine), Associate Professor, Professor, Department of Pathological Physiology, South Ural State Medical University.

454048, Chelyabinsk, Vorovsky str., 64.

Phone: 7 (908) 060-92-06.

Russian Federation

M. V. Osikov

South Ural State Medical University

Email: prof.osikov@yandex.ru

PhD, MD (Medicine), Professor, Head, Department of Pathological Physiology, South Ural State Medical University.

454048, Chelyabinsk, Vorovsky str., 64.

Russian Federation

A. E. Bakeeva

South Ural State Medical University

Email: a.bakeeva01@yandex.ru

Assistant Professor, Department of Pharmacology, South Ural State Medical University.

454048, Chelyabinsk, Vorovsky str., 64.

Russian Federation

N. V. Kaigorodtseva

South Ural State Medical University

Email: nkaigorodceva@yandex.ru

Assistant Professor, the Department of Pathological Physiology, South Ural State Medical University.

454048, Chelyabinsk, Vorovsky str., 64.

Russian Federation

References

  1. Долгушина А.И., Хусаинова Г.М., Василенко Г.М., Кононенко А.Г. Распространенность воспалительных заболеваний кишечника в Челябинской области // Альманах клинической медицины, 2019. Т. 47, № 6. С. 511-517.
  2. Дьяченко П.А., Дьяченко А.Г. Клетки Th17 и их роль в возникновении аутоиммунных заболеваний // 1мунолопя та алерголопя: наука i практика, 2011. № 2. С. 4-10.
  3. Bo L., Fu H., Yang J. Comprehensive analysis of gene expression profiles provides insight into the pathogenesis of Crohn's disease. Mol. Med. Rep., 2018, Vol.18, no. 3, pp. 2643-2650.
  4. Borecki K., Zawada I., Salkic N.N., Karakiewicz B., Adler G. Relationship between the IL23R SNPs and Crohn's disease susceptibility and phenotype in the polish and bosnian populations: a case-control study. Int. J. Environ. Res. Public Health, 2019, Vol. 16, no. 9, 1551. doi: 10.3390/ijerph16091551.
  5. Burisch J., Munkholm P. The epidemiology of inflammatory bowel disease. Scand. J. Gastroenterol., 2015, Vol. 50, no. 8, pp. 942-951.
  6. Cаtanа C.S., Neagoe I.B., Cozma V, Magda§ C., Tabaran F., Dumitra§cu D.L. Contribution of the IL-17/ IL-23 axis to the pathogenesis of inflammatory bowel disease. World J. Gastroenterol., 2015, Vol. 21, no. 19, pp. 58235830.
  7. Corridoni D., Arseneau K.O., Cominelli F. Inflammatory bowel disease. Immunol. Lett., 2014, Vol. 161, no. 2, pp. 231-235.
  8. Galvez J. Role of Th17 cells in the pathogenesis of human IBD. ISRNInflamm., 2014, Vol. 2014, 928461. doi: 10.1155/2014/928461.
  9. Heller F., Fuss I.J., Nieuwenhuis E.E., Blumberg R.S., Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis is mediated by IL13-producing NK-T cells. Immunity, 2002, Vol. 17, no. 5, pp. 629-638.
  10. Jiang W., Su J., Zhang X., Cheng X., Zhou J., Shi R., Zhang H. Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease. Inflamm. Res., 2014, Vol. 63, no. 11, pp. 943-950.
  11. Korolkova O.Y., Myers J.N., Pellom S.T., Wang L., M'Koma A.E. Characterization of serum cytokine profile in predominantly colonic inflammatory bowel disease to delineate ulcerative and crohn's colitides. Clin. Med. Insights. Gastroenterol., 2015, Vol. 8, pp. 29-44.
  12. Lai L.J., Shen J., Ran Z.H.. Natural killer T cells and ulcerative colitis. Cell. Immunol., Vol. 335, pp. 1-5.
  13. Lee S.H., Kwon J.E., Cho M.L. Immunological pathogenesis of inflammatory bowel disease. Intest. Res., 2018, Vol. 16, no. 1, pp. 26-42.
  14. Omenetti S., Pizarro T.T. The Treg/Th17 axis: a dynamic balance regulated by the gut microbiome/ S. Omenetti. Front. Immunol., 2015, Vol. 6, 639. doi: 10.3389/fimmu.2015.00639.
  15. Singh U.P., Singh N.P., Murphy E.A. Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine, 2016, Vol. 77, pp. 44-49.

Supplementary files

There are no supplementary files to display.


Copyright (c) 2021 Davydova E.V., Osikov M.V., Bakeeva A.E., Kaigorodtseva N.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Свидетельство о регистрации СМИ ПИ № 77 - 11525 от 04.01.2002 выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies